3:43 PM
 | 
Feb 14, 2018
 |  BC Extra  |  Preclinical News

Three targets in the same brain region could alleviate depression

A Zhejiang University team published a pair of papers in Nature suggesting ketamine works by modulating the firing of neurons in the lateral habenula, a brain region that controls reward signaling. The studies point to three different targets in the brain structure that could be used to create a more selective therapy.

Ketamine, an NMDA receptor antagonist, has been shown to alleviate depression symptoms more quickly than marketed...

Read the full 317 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$35 USD
More Info >